Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
12.63
-0.15 (-1.17%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Lyell Immunopharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Lyell Immunopharma stock has a consensus rating of "Buy" and an average price target of $38.14. The average 1-year stock price forecast is 201.98% higher than the current stock price, while the lowest is $12 (-4.99%) and the highest is $49 (+287.97%).
Price Target: $38.14 (+201.98%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lyell Immunopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 6 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Initiates $44 | Buy | Initiates | $44 | +248.38% | Jul 22, 2026 |
| Needham | Needham | Buy Maintains $44 | Buy | Maintains | $44 | +248.38% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +256.29% | Jun 9, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $12 | Sell | Reiterates | $12 | -4.99% | Jun 3, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Initiates $49 | Buy | Initiates | $49 | +287.97% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
11.71K
from 36.00K
Decreased by -67.47%
Revenue Next Year
6.74M
from 11.71K
Increased by 57,466.01%
EPS This Year
-5.70
EPS Next Year
-3.35
from -5.70
EPS and Forward PE are based on non-GAAP adjusted numbers.